- Home
- BMRN vs CFR Comparison
BMRN vs CFR Comparison
Compare BMRN & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRN | CFR |
|---|---|---|
| Founded | 1996 | 1868 |
| Country | United States | United States |
| Employees | N/A | 6008 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 8.5B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMRN | CFR |
|---|---|---|
| Price | $58.97 | $154.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 13 |
| Target Price | $88.22 | ★ $142.31 |
| AVG Volume (30 Days) | ★ 1.9M | 619.0K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $9.72 |
| Revenue Next Year | $12.23 | $4.70 |
| P/E Ratio | $109.20 | ★ $14.55 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $119.00 |
| 52 Week High | $66.28 | $157.34 |
Technical Indicators
Market Signals| Indicator | BMRN | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 61.76 | 70.78 |
| Support Level | $53.32 | $133.49 |
| Resistance Level | $61.92 | N/A |
| Average True Range (ATR) | 1.49 | 2.85 |
| MACD | 0.19 | 0.70 |
| Stochastic Oscillator | 85.48 | 81.92 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $52 billion in assets (as of March 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.